Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rev Med Liege ; 73(7-8): 413-418, 2018 Jul.
Artigo em Francês | MEDLINE | ID: mdl-30113785

RESUMO

The primary vaginal melanoma is a rare aggressive tumour with a poor prognosis. The average age at diagnosis is 60, and there are no known risk factors. The establishment of a classification system and treatment protocols are made difficult because there are so few cases. The 5-year survival rate is estimated at no more than ten per cent. We report a case of an inoperable primary vaginal melanoma in a 58-year old woman. There were metastatic lymph nodes in the lumbo-aortic region, but no extension to bone or viscera. She was treated with nivolumab as monotherapy. Clinical and radiological evolution were both favourable, and the treatment was well tolerated.


Le mélanome vaginal primitif est une tumeur rare, agressive et de mauvais pronostic. L'âge moyen lors du diagnostic est de 60 ans et les facteurs de risque sont inconnus. La rareté de cette pathologie complique l'établissement d'un système de classification et d'un protocole de prise en charge. Le taux de survie à 5 ans ne dépasse pas les 10 %. Nous présentons le cas d'une patiente de 58 ans atteinte d'un mélanome vaginal non opérable avec envahissement ganglionnaire lymphatique lombo-aortique sans métastase osseuse ou viscérale. Un traitement par nivolumab est instauré en monothérapie. L'évolution clinique et radiologique est favorable avec une tolérance au traitement satisfaisante.


Assuntos
Melanoma/patologia , Neoplasias Vaginais/patologia , Anticorpos Monoclonais/uso terapêutico , Feminino , Humanos , Melanoma/tratamento farmacológico , Melanoma/cirurgia , Pessoa de Meia-Idade , Nivolumabe , Neoplasias Vaginais/tratamento farmacológico , Neoplasias Vaginais/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...